Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

New study confirms that drinking diet beverages helps people lose weight

A groundbreaking new study published today in Obesity, the journal of The Obesity Society, confirms definitively that drinking diet beverages helps people lose weight.

28 May 2014

Researchers discover novel enzyme that promotes insulin secretion in type 2 diabetes animal model

A signal that promotes insulin secretion and reduces hyperglycemia in a type 2 diabetes animal model is enhanced by the inhibition of a novel enzyme discovered by CHUM Research Centre (CRCHUM) and University of Montreal researchers.

26 May 2014

Consistent glycaemic control wards off diabetic complications

Variability in glycaemic control is associated with both microvascular and macrovascular events in patients with Type 2 diabetes, shows an analysis of the ADVANCE trial.

23 May 2014

First Edition: May 23, 2014

Today's early morning highlights from the major news organizations, including the latest developments on the Department of Veterans Affairs controversy.

23 May 2014

European Commission grants Marketing Authorization for empagliflozin for treatment of type 2 diabetes

The European Commission has granted Marketing Authorisation for empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor from Boehringer Ingelheim and Eli Lilly and Company.

23 May 2014

Researchers identify mutation in fat-storage gene that appears to increase risk for type 2 diabetes

Researchers at the University of Maryland School of Medicine have identified a mutation in a fat-storage gene that appears to increase the risk for type 2 diabetes and other metabolic disorders, according to a study published online today in the New England Journal of Medicine.

23 May 2014

EKF affirms that novel sTNFR1/2 biomarkers can help predict end-stage renal disease

EKF, confirms scientific evidence as validation that soluble TNF Receptors 1 and 2 are strong biomarkers of progressive Diabetic Kidney Disease.

From EKF Diagnostics 23 May 2014

Pain receptors may hold key to treating obesity, diabetes and improving metabolic health

Blocking a pain receptor in mice not only extends their lifespan, it also gives them a more youthful metabolism, including an improved insulin response that allows them to deal better with high blood sugar.

23 May 2014

St. Jude Medical's EnligHTN renal denervation system safe, effective for treating drug-resistant hypertension

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced preliminary results from the EnligHTN III study, which found the company's second-generation EnligHTN™ renal denervation system provided safe and effective therapy for patients with drug-resistant, uncontrolled hypertension six months post-procedure. The results were presented during a hot line late-breaking clinical trial session at EuroPCR 2014.

22 May 2014

Research validates family history screening questionnaire as tool to cover multiple conditions

The family history screening questionnaire can be used to provide insight into people's susceptibility to breast, ovarian, bowel and prostate cancer, melanoma, ischaemic heart disease and type 2 diabetes.

22 May 2014

Study examines how interactive games help people with Type 2 diabetes make better choices

Type 2 diabetes is a chronic disease of global relevance. Due to the fear that comes with the long-term bodily degenerative processes, people with the disease often do not actively seek information on the health risks.

22 May 2014

Study looks at stem cells to pinpoint how excess fat is stored

With three million people dying worldwide each year as a direct result of being overweight or obese, a new study will look at stem cells to pinpoint how excess fat is stored - potentially paving the way for new treatments to combat killer diseases associated with obesity.

22 May 2014

BioLineRx announces financial results for Q1 2014, provides operational update

BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today reported its financial results for first quarter ended March 31, 2014.

20 May 2014

Low physical activity, heavy use of electronic media linked to increased health risk in children

The Physical Activity and Nutrition in Children Study, PANIC, carried out by the Institute of Biomedicine at the University of Eastern Finland shows that low levels of physical activity combined with heavy use of electronic media and sedentary behaviour are linked to an increased risk for type 2 diabetes and vascular diseases already in 6-8 year-old children.

20 May 2014

Biovision provides list of businesses, projects selected for Investor Conference and Catalyzer sessions

Biovision, the annual forum on future-oriented research in life sciences, today announces the list of biotech and medtech companies and projects selected for the Investor Conference and Catalyzer sessions. Awards will be presented during the closing ceremony.

20 May 2014

Breastfeeding initiation and success impacted by diabetes status of mother

Women diagnosed with diabetes before or during pregnancy are less likely to initiate and continue breastfeeding their newborns than women without diabetes, a new study suggests. Led by clinician-scientists in The Research Institute at Nationwide Children's Hospital and collaborating institutions, the findings point to areas for improved prenatal and postnatal education of women with diabetes.

20 May 2014

Study shows technology improves transition into adulthood for adolescents with chronic disease

Adolescents with chronic diseases (ACD), such as cystic fibrosis, gastrointestinal disorders (including Crohn's disease) and Type 1 diabetes, often find the transition of managing their health care needs into adulthood to be challenging.

19 May 2014

Data from phase III trials supports safety, efficacy of linagliptin in treating T2D in African-American adults

Data from a retrospective pooled analysis of eight phase III trials (two 18-week and six 24-week) of linagliptin 5 mg once-daily, showed reductions from baseline A1c at 18 (eight trials) and 24 (six trials) weeks compared to placebo in African-American adults with type 2 diabetes (T2D),

16 May 2014

CVD risk factors may differ between men and women with type 2 diabetes, shows study

Type 2 diabetes greatly increases a person's risk of developing cardiovascular disease (CVD). A new study showing that cardiovascular risk factors such as elevated blood pressure and cholesterol levels differ significantly between men and women is published in Diabetes Technology & Therapeutics (DTT), a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

16 May 2014

Transition Therapeutics begins TT-401 Phase 2 clinical study for treatment of type 2 diabetes

Transition Therapeutics Inc. today announced the dosing of the first patient in a Phase 2 clinical study of TT-401 (LY2944876), a drug candidate for the treatment of type 2 diabetes.

15 May 2014

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

New study confirms that drinking diet beverages helps people lose weight

Researchers discover novel enzyme that promotes insulin secretion in type 2 diabetes animal model

Consistent glycaemic control wards off diabetic complications

First Edition: May 23, 2014

European Commission grants Marketing Authorization for empagliflozin for treatment of type 2 diabetes

Researchers identify mutation in fat-storage gene that appears to increase risk for type 2 diabetes

EKF affirms that novel sTNFR1/2 biomarkers can help predict end-stage renal disease

Pain receptors may hold key to treating obesity, diabetes and improving metabolic health

St. Jude Medical's EnligHTN renal denervation system safe, effective for treating drug-resistant hypertension

Research validates family history screening questionnaire as tool to cover multiple conditions

Study examines how interactive games help people with Type 2 diabetes make better choices

Study looks at stem cells to pinpoint how excess fat is stored

BioLineRx announces financial results for Q1 2014, provides operational update

Low physical activity, heavy use of electronic media linked to increased health risk in children

Biovision provides list of businesses, projects selected for Investor Conference and Catalyzer sessions

Breastfeeding initiation and success impacted by diabetes status of mother

Study shows technology improves transition into adulthood for adolescents with chronic disease

Data from phase III trials supports safety, efficacy of linagliptin in treating T2D in African-American adults

CVD risk factors may differ between men and women with type 2 diabetes, shows study

Transition Therapeutics begins TT-401 Phase 2 clinical study for treatment of type 2 diabetes

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in